January 22, 2021 by Chain Drug Review
Chip Davis, COVID-19, HDA, health care distribution industry
Leading Headlines, Pharmacy

ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released the following statement in response to recent commentary related to the COVID-19 vaccination effort: “HDA and the health care distribution industry are committed to doing whatever is necessary to assist the Biden administration in meeting its goal of administering 100 million vaccines to
January 14, 2021 by Chain Drug Review
2021 Distribution Management Conference (DMC), HDA
Leading Headlines

WASHINGTON — The 2021 Distribution Management Conference (DMC) and Expo has been rescheduled for Tuesday, August 10─Friday, August 13, 2021, at the JW Marriott Indianapolis. This decision was made given the increasing availability of COVID-19 vaccines in the U.S., feedback from HDA member executives on evolving company-wide travel restrictions as well as the safety protocols instituted
January 13, 2021 by Bill Schiffner
HDA, HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders
Leading Headlines, Pharmacy

ARLINGTON, Va. — The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders. “Our Foundation scholars represent the curiosity and dedication of the people that make up our industry — who work to ensure the safe and reliable delivery of lifesaving medicines and healthcare products in the U.S. each and every
December 22, 2020 by Chain Drug Review
Chip Davis, COVID-19 emergency relief package, HDA
Pharmacy

ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate. “HDA applauds Congress for passing the bipartisan economic stimulus package that will provide much needed relief to the businesses and millions of
December 11, 2020 by Chain Drug Review
Chip Davis, COVID-19 vaccine, HDA
Pharmacy

ARLINGTON, Va. — HDA president and CEO Chester “Chip” Davis, Jr., released the following statement on the U.S. Food and Drug Administration’s (FDA) decision to grant Emergency Use Authorization of the first COVID-19 vaccine, manufactured by Pfizer and BioNTech: “Today’s decision by the FDA marks a historic turning point in the fight against this global
November 2, 2020 by Chain Drug Review
HDA, Healthcare Distribution Alliance (HDA) Research Foundation
Leading Headlines, Pharmacy

ARLINGTON, Va. — A survey released today by the Healthcare Distribution Alliance (HDA) Research Foundation indicates the pharmaceutical supply chain continues to make steady progress to comply with the 2013 Drug Supply Chain Security Act (DSCSA); however, some implementation priorities have shifted amid the initial industry response to the COVID-19 pandemic. The Serialization Readiness Survey, released in conjunction
October 26, 2020 by Chain Drug Review
Chester "Chip" Davis, COVID-19, HDA
Leading Headlines, Pharmacy

ARLINGTON, Va. — A report published by the Healthcare Distribution Alliance (HDA) Research Foundation and Deloitte Consulting found that during the first 90 days of the COVID-19 pandemic, the biopharmaceutical finished goods industry quickly adapted and adjusted to deliver medicines safely and efficiently to patients, with only minimal disruptions. As noted in the report, The First
October 8, 2020 by Chain Drug Review
HDA, HDA’s Pharmaceutical Cargo Security Coalition
Pharmacy

ARLINGTON, Va. — HDA’s Pharmaceutical Cargo Security Coalition recognized three outstanding supply chain security professionals today through the annual PCSC Awards. Presented virtually as part of the PCSC Online Seminar, the awards honor leaders who demonstrate the highest standards of honesty and integrity, while undertaking extraordinary efforts to serve and protect their communities. The 2020 honorees
October 5, 2020 by Chain Drug Review
HDA, Robert Mauch
Leading Headlines, Pharmacy

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) today announces the election of Robert Mauch, EVP and group president of AmerisourceBergen Corp., as chairman of the HDA board of directors. Chad Gielen, president/CEO of Louisiana Wholesale Drug Co., will serve as vice chairman. Mauch, who served as HDA vice chairman for two years, assumes Board
June 18, 2020 by Chain Drug Review
COVID-19, HDA, supply chain
Leading Headlines, Pharmacy

ARLINGTON, Va. — HDA and its distributor-member companies continue to work with partners across the pharmaceutical supply chain and public sector in response to COVID-19. Below are new resources that provide insight into our industry’s efforts: HDA Principles for Pandemic and Public Health Emergency Response: Released on June 11, HDA reaffirmed the industry’s commitment to assisting
June 11, 2020 by Chain Drug Review
Chip Davis, COVID-19, HDA, supply chain
Leading Headlines, Pharmacy

ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during pandemics and public health emergencies. HDA highlights four priority areas: Supply Chain Coordination: Coordination between the public and private sector is key to addressing public health crises. Accordingly, a consolidated contact within the
June 2, 2020 by Brian Bossetta
Chip Davis, COVID-19, HDA, HDA (formerly known as the Healthcare Distribution Management Association)
Leading Headlines, News, Pharmacy, Supplier News

ARLINGTON, Va. — Taking on a new leadership role is never easy; taking the helm during a global pandemic, however, especially when job No. 1 for the organization’s members involves keeping the country’s vital medical supply chain running smoothly, defines daunting. But being named president and chief executive officer of the Healthcare Distribution Alliance
May 20, 2020 by Chain Drug Review
Chip Davis, COVID-19, HDA
Leading Headlines, Pharmacy, Supplier News

ARLINGTON, Va. — HDA has released a two-minute video that further reinforces the pharmaceutical distribution industry’s critical function as it adapts and rises to the challenge of COVID-19, while also continuing the vital work of delivering the medicines Americans rely on to manage their daily health care needs. The video features HDA president and CEO
April 17, 2020 by Chip Davis
Chip Davis, COVID-19, HDA
Opinion

Across the country, brave, frontline health care professionals are working around the clock as our nation grapples with the COVID-19 pandemic. These workers — the true heroes of the pandemic — are treating patients, maintaining vital health care operations and serving as emergency responders. In this time of crisis, it is also important to remember